Komori
Noevir Holdings (4928) · PolicyRestated

Funding Based Primarily on Cash on Hand and Allocation to Retained Earnings and R&D

First written in FY2021. 4 of 5 entries say "Restated". Latest entry: FY2025.

5entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20252021: 12022: 120222023: 120232024: 120242025: 12025
Same theme, other companies
Balancing Growth Investment with a Stronger Financial FoundationA theme 99 companies write about · 0 as a headwind · 98 as a tailwind

The whole theme swung hardest in 2025: 6 of 56 companies on the "Worse" side.

52 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 99 companies compared. The sentences above are computed from all 99.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「The Group’s funding is primarily financed from cash on hand.」

    The policy of primarily funding operations from cash on hand, strengthening the financial position through retained earnings, and allocating funds to research and development has continued.
  2. FY2024RestatedAnnual report

    「Regarding the use of funds going forward, the Group will strengthen its financial position through retained earnings while actively engaging in research and development and other activities to generate future cash flow and improve capital efficiency.」

    The policy of primarily funding operations from cash on hand, strengthening the financial position through retained earnings, and allocating funds to research and development has continued.
  3. FY2023RestatedAnnual report

    「The Group’s funding is primarily financed from cash on hand. Regarding the use of funds going forward, the Group will strengthen its financial position through retained earnings while actively engaging in research and development and other activities to generate future cash flow and improve capital efficiency.」

    The policy of primarily funding operations from cash on hand, strengthening the financial position through retained earnings, and allocating funds to research and development has continued.
  4. FY2022RestatedAnnual report

    「The Group’s funding is primarily financed from cash on hand. Regarding the use of funds going forward, the Group will strengthen its financial position through retained earnings while actively engaging in research and development and other activities to generate future cash flow and improve capital efficiency.」

    The policy of primarily funding operations from cash on hand, strengthening the financial position through retained earnings, and allocating funds to research and development has continued.
  5. FY2021First statedAnnual report

    「The Group’s funding is primarily financed from cash on hand. Regarding the use of funds going forward, the Group will strengthen its financial position through retained earnings while engaging in research and development and other activities to generate future cash flow and improve capital efficiency.」

    The policy of primarily funding operations from cash on hand, strengthening the financial position through retained earnings, and allocating funds to research and development and other activities was presented as a consolidated topic for the first time.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Noevir Holdings's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.